March 20, 2023

Ascidian Therapeutics Appoints Jay A. Barth, M.D., as Chief Medical Officer

January 4, 2023

Ascidian Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

October 12, 2022

Ascidian Therapeutics Launches to Rewrite RNA